CCO Oncology Podcast

189 Folgen

1. BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges

   Vom: 5.4.2023
2. Experts Discuss Claudin 18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers

   Vom: 28.3.2023
3. Treatment Considerations for Patients With Essential Thrombocythemia: A Conversation Between Experts

   Vom: 23.2.2023
4. FAQs on the Use of Asparaginase Therapy in Young and Older Adults With Acute Lymphoblastic Leukemia

   Vom: 20.2.2023
5. Experts Answer Questions on the Management of Patients With T-Cell Lymphomas

   Vom: 17.2.2023
6. Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

   Vom: 17.2.2023
7. Individualizing Care for Patients With Triple-Negative Breast Cancer

   Vom: 18.1.2023
8. Contemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts

   Vom: 11.1.2023
9. HCC Surveillance: Challenges and Opportunities

   Vom: 3.1.2023
10. A Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer

    Vom: 13.12.2022
11. Expert Thoughts on Studies of Interest Presented at the 2022 ESGO Annual Meeting on Gynecologic Cancers

    Vom: 29.11.2022
12. The Transgender Cancer Experience: A Conversation Between an Oncologist and a Transmasculine Individual on Navigating the Healthcare System

    Vom: 29.11.2022
13. Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions

    Vom: 9.11.2022
14. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting

    Vom: 28.10.2022
15. Expert Thoughts on Key Trials of Interest for Ovarian and Cervical Cancer at the IGCS 2022 Annual Global Meeting

    Vom: 24.10.2022
16. Relapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape

    Vom: 24.10.2022
17. Expert Insights on Key Updates From the 2022 ESMO Congress on PARP Inhibitors in Ovarian Cancer

    Vom: 4.10.2022
18. Managing EGFR-Mutated Non-Small-Cell Lung Cancer in Today’s Clinic: Expert Answers to Frequently Asked Questions

    Vom: 28.9.2022
19. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the Pan Pacific Lymphoma Conference 2022

    Vom: 30.8.2022
20. Experts Discuss Challenges in Advanced Hepatocellular Carcinoma Management

    Vom: 22.8.2022